mevastatin has been researched along with cholestyramine resin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, S | 1 |
| Fukui, T; Ito, M; Saito, T; Tomita, K | 1 |
| Funahashi, T; Kishino, B; Matsuzawa, Y; Yamamoto, A; Yamamura, T; Yokoyama, S | 1 |
| Matsuzawa, Y; Sudo, H; Yamamoto, A; Yamamura, T; Yokoyama, S | 1 |
| Maxwell, RE; Nawrocki, JW; Uhlendorf, PD | 1 |
| Edwards, PA; Fogelman, AM; Kane, J; Lemongello, D; Shechter, I | 1 |
| Koizumi, J; Mabuchi, H; Sakai, T; Sakai, Y; Takeda, R; Wakasugi, T; Watanabe, A; Yoshimura, A | 1 |
| de Lange, J; Kempen, HJ; Vos-van Holstein, M | 1 |
| Fears, R; Ferres, H; Richards, DH | 1 |
9 other study(ies) available for mevastatin and cholestyramine resin
| Article | Year |
|---|---|
[Study on the effects of the hypocholesteremic agents, cholestyramine and compactin on the induction of renal tumors in rats by N-ethyl-N-hydroxyethyl nitrosamine].
Topics: Animals; Anticholesteremic Agents; Butylhydroxybutylnitrosamine; Carcinoma, Renal Cell; Cholesterol; Cholestyramine Resin; Kidney Neoplasms; Lovastatin; Male; Rats; Rats, Inbred Strains | 1992 |
Acetoacetyl-CoA synthetase specific activity and concentration in rat tissues.
Topics: Animals; Antibodies; Anticholesteremic Agents; Cholesterol, Dietary; Cholestyramine Resin; Coenzyme A Ligases; Enzyme-Linked Immunosorbent Assay; Immunodiffusion; Kinetics; Liver; Lovastatin; Male; Naphthalenes; Rats; Rats, Inbred Strains; Tissue Distribution | 1986 |
Effects of probucol on xanthomata regression in familial hypercholesterolemia.
Topics: Achilles Tendon; Adolescent; Adult; Aged; Anticholesteremic Agents; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Phenols; Plasmapheresis; Probucol; Xanthomatosis | 1986 |
Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Drug Therapy, Combination; Female; Heterozygote; Homozygote; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Lipids; Lovastatin; Male; Naphthalenes | 1984 |
Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
Topics: Animals; Anticholesteremic Agents; Bezafibrate; Caprylates; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Gemfibrozil; Hypolipidemic Agents; Liver; Lovastatin; Male; Mevalonic Acid; Naphthalenes; Pentanoic Acids; Rats; Rats, Inbred F344; Sterols; Valerates | 1983 |
Properties of purified rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and regulation of enzyme activity.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Fluorides; Hydroxymethylglutaryl CoA Reductases; Immune Sera; Immunoassay; Immunodiffusion; Kinetics; Lovastatin; Microsomes, Liver; Molecular Weight; Naphthalenes; Octoxynol; Polyethylene Glycols; Protein Conformation; Rats | 1980 |
Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Drug Evaluation; Drug Therapy, Combination; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Phospholipids; Triglycerides | 1983 |
Bile acids and lipids in isolated rat hepatocytes. II. Source of cholesterol used for bile acid formation, estimated by incorporation of tritium from tritiated water, and by the effect of ML-236B.
Topics: Animals; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Lipid Metabolism; Liver; Lovastatin; Naphthalenes; Rats; Tritium | 1983 |
The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
Topics: Animals; Anticholesteremic Agents; Chickens; Cholesterol; Cholestyramine Resin; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, VLDL; Lovastatin; Male; Naphthalenes; Rats | 1980 |